EE200000048A - Uudsed ühendid - Google Patents

Uudsed ühendid

Info

Publication number
EE200000048A
EE200000048A EEP200000048A EEP200000048A EE200000048A EE 200000048 A EE200000048 A EE 200000048A EE P200000048 A EEP200000048 A EE P200000048A EE P200000048 A EEP200000048 A EE P200000048A EE 200000048 A EE200000048 A EE 200000048A
Authority
EE
Estonia
Prior art keywords
pct
novel compounds
sec
date
compounds
Prior art date
Application number
EEP200000048A
Other languages
English (en)
Estonian (et)
Inventor
Brown Roger
Pairaudeau Garry
Original Assignee
Astra Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceuticals Limited filed Critical Astra Pharmaceuticals Limited
Publication of EE200000048A publication Critical patent/EE200000048A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
EEP200000048A 1997-07-22 1998-07-15 Uudsed ühendid EE200000048A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
PCT/SE1998/001394 WO1999005144A1 (en) 1997-07-22 1998-07-15 Novel compounds

Publications (1)

Publication Number Publication Date
EE200000048A true EE200000048A (et) 2000-10-16

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000048A EE200000048A (et) 1997-07-22 1998-07-15 Uudsed ühendid

Country Status (21)

Country Link
US (1) US6166022A (sv)
EP (1) EP0998475B1 (sv)
JP (1) JP2001510843A (sv)
KR (1) KR20010022084A (sv)
CN (1) CN1270591A (sv)
AT (1) ATE216390T1 (sv)
AU (1) AU8370798A (sv)
BR (1) BR9811028A (sv)
CA (1) CA2296426A1 (sv)
DE (1) DE69804966T2 (sv)
EE (1) EE200000048A (sv)
HU (1) HUP0003826A3 (sv)
ID (1) ID25856A (sv)
IL (1) IL134111A0 (sv)
IS (1) IS5352A (sv)
NO (1) NO20000313L (sv)
PL (1) PL338181A1 (sv)
SE (1) SE9702774D0 (sv)
SK (1) SK188299A3 (sv)
TR (1) TR200000152T2 (sv)
WO (1) WO1999005144A1 (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
ID27127A (id) * 1998-02-17 2001-03-01 Astrazeneca Uk Ltd SENYAWA-SENYAWA TRIAZOLO (4,5-d) PIRIMIDINA YANG BARU
JP2003508511A (ja) 1999-09-09 2003-03-04 カイロテック・テクノロジー・リミテッド 置換シクロペンテン、その調製、およびキラル骨格のためのその使用
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
US7109332B2 (en) 2003-10-03 2006-09-19 Portola Pharmaceuticals, Inc. 2,4-dioxo-3-quinazolinylaryl sulfonylureas
EP1667989A4 (en) 2003-10-03 2008-08-20 Portola Pharm Inc SUBSTITUTED ISOQUINOLEINONES
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
ATE469157T1 (de) 2003-10-21 2010-06-15 Inspire Pharmaceuticals Inc Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
MX2007003836A (es) 2004-09-29 2007-08-20 Portola Pharm Inc 2h-1,3-benzoxazin-4(3h)-onas sustituidas.
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JPWO2007020935A1 (ja) * 2005-08-17 2009-02-26 小野薬品工業株式会社 Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
US20070208045A1 (en) 2005-11-03 2007-09-06 Portola Pharmaceuticals, Inc. Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
US7566722B2 (en) 2006-10-31 2009-07-28 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
WO2011133871A2 (en) * 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. 5'-end derivatives
WO2011150205A2 (en) * 2010-05-27 2011-12-01 Dr. Reddy's Laboratories Ltd. Highly selective asymmetric hydroformylation of (1s,4r) or (1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3- one (+) or (-)-lactam
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
AU673055B2 (en) * 1993-02-03 1996-10-24 Gensia, Inc. Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
HU221880B1 (hu) * 1995-07-11 2003-02-28 Astrazeneca Ab, Vérlemezke-aggregáció inhibitorok, ezeket tartalmazó gyógyszerkészítmények és előállításuk

Also Published As

Publication number Publication date
JP2001510843A (ja) 2001-08-07
DE69804966T2 (de) 2002-11-07
US6166022A (en) 2000-12-26
PL338181A1 (en) 2000-10-09
IL134111A0 (en) 2001-04-30
TR200000152T2 (tr) 2000-07-21
WO1999005144A1 (en) 1999-02-04
CA2296426A1 (en) 1999-02-04
HUP0003826A3 (en) 2001-11-28
CN1270591A (zh) 2000-10-18
ATE216390T1 (de) 2002-05-15
EP0998475A1 (en) 2000-05-10
DE69804966D1 (de) 2002-05-23
IS5352A (is) 2000-01-19
ID25856A (id) 2000-11-09
NO20000313L (no) 2000-03-22
HUP0003826A2 (hu) 2001-04-28
EP0998475B1 (en) 2002-04-17
NO20000313D0 (no) 2000-01-21
KR20010022084A (ko) 2001-03-15
BR9811028A (pt) 2000-08-01
SE9702774D0 (sv) 1997-07-22
SK188299A3 (en) 2000-08-14
AU8370798A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
EE200000048A (et) Uudsed ühendid
SE9702772D0 (sv) Novel compounds
TR200000197T2 (tr) Yeni bileşimler
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
SE9702564D0 (sv) New compounds
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
SE9702563D0 (sv) Compounds
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
NO970473L (no) N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika
SE9802574D0 (sv) Novel compounds
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
MX9603199A (es) Antagonistas de receptores a endotelina.
BG101328A (en) New derivatives of imidazoloquinaxalon with heterocyclic substituents, their preparation and use
SE0004099D0 (sv) Novel compounds
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
RS47004A (en) Hexacyclic compounds